Is Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology SCI Indexed? Indexing Status & Metrics

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor

4.08

Citation rate 7.20 691 total citations

h5-index 33 h5 depth signal

Cited share 90.0% 90 of 100

Total citations 691 Citation footprint

Metric signal 6.56 External metric anchor

Self-citation 1.6% 11 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 295

China 168

India 39

Germany 26

Italy 25

Citing Fields of Research

Neurodegenerative Disorders 237

Immunology 154

HIV 136

Neurosciences 68

Substance Abuse 58

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 1,311 Articles tracked across the journal lifetime

Indexed publication set 100 90 cited publications

Last 12 months 79 6.6 publications/month

Open access share 29.1% 23 OA publications in the last year

Leading citing country United States 295 citing publications

Leading citing field Neurodegenerative Disorders 237 citing publications

Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE

v1n1, Mar. 2006-

PubMed

v1n1, Mar. 2006-

Research Focus & Classification

Indexed Subjects

Neurodegenerative Disorders Immunology Anesthetic & Pain Medicine Neuromuscular Disorders Neurosciences HIV

Issuing & Sponsoring Bodies

Contributor

Society on NeuroImmune Pharmacology

Broad Categories

Allergy and Immunology Neurology Pharmacology Neurodegenerative Disorders Neuromuscular Disorders HIV Anesthetic & Pain Medicine Neurodevelopmental Disorders Musculoskeletal Disorders

MeSH Descriptors

Allergy and Immunology Neuropharmacology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01 19 October 2026

DOI 10.1007/s11481-026-10323-9

Green-synthesized Nanoparticles as Emerging Antidepressant and Anxiolytic Candidates: A Critical Review of Preclinical Evidence and Translational Prospects

Open DOI

Meesala Krishna Murthy, Dibyaranjan Samal

02 9 October 2026

DOI 10.1007/s11481-026-10320-y

Fraxetin Ameliorates Cognitive Impairment in STZ-Induced Mice: Involvement of Suppressed Microglial Hyperactivation and Improved Mitochondrial Dysfunction

Open DOI

Jun Zhao, Yiming Bai, Chao Wang et al.

03 7 October 2026

DOI 10.1007/s11481-026-10322-w

Dietary Supplementation with Omega-3 Fatty Acids Rescues Neurodevelopmental Deficits in a Combined Exposure Paradigm of Maternal Oxycodone Exposure and Chronic Stress

Open DOI

Vamsi K. Singu, Nghi M. Nguyen, Alexander Ky et al.

04 7 October 2026

DOI 10.1007/s11481-026-10321-x

Beyond Histamine Blockade: Clemastine Fumarate as a Promoter of Myelin Regeneration, Inflammatory Regulation, and Neuroimmune Modulation in CNS Disorders

Open DOI

Rohit Kumar Singh, Chandrayee Banerjee, Sidharth Mehan

05 19 September 2026

DOI 10.1007/s11481-026-10319-5

Pharmacological Profiling of Mefenamic Acid Derivative (2-((2,3-dimethylphenyl)amino)phenyl)(4-ethylpiperazin-1-yl)methone) for its Antidepressant- and Anxiolytic-like Potential Using Corticosterone Induced Depression Model in Rodents

Open DOI

Ishwar Purushottam Kokate, Thangaraj Devadoss, Vaishnavi G. Thorat et al.

06 16 September 2026

DOI 10.1007/s11481-026-10304-y

Sacral Nerve Modulation Alleviates Neuropathic Pelvic Pain Through Modulation of the Spinal Immune Microenvironment and Microglial Activation

Open DOI

Jinming Zuo, Yang Wang, Lixin Yang et al.

To investigate the efficacy of sacral neuromodulation (SNM) in alleviating neuropathic pelvic pain (NPP) and its underlying neuroimmune mechanisms, focusing on microglial activation and the CX3CL1-CX3CR1 pathway. A rat model of NPP was e...

07 12 September 2026

DOI 10.1007/s11481-026-10314-w